Immunoprotein Diagnostic Testing Market USD 15.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
The global immunoprotein diagnostic testing market is estimated to reach USD 15.8 Billion in 2020, expanding at a CAGR of 4.3% from 2016 to 2020.
Maryland Heights, MO, October 12, 2016 --(PR.com)-- According to a market research report Immunoprotein Diagnostic Testing Market 2013-2020 published by iHealthcareAnalyst, Inc., the global immunoprotein diagnostic testing market is estimated to reach USD 15.8 Billion in 2020, expanding at a CAGR of 4.3% from 2016 to 2020.
Visit the Immunoprotein Diagnostic Testing Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/immunoprotein-diagnostic-testing-market/
The global immunoprotein diagnostic testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The global immunoprotein diagnostic testing market segmentation is based on assay technologies (chemiluminescence assay, enzyme based immunoassay, immunofluorescence assay, immunoprotein electrophoresis, immunoturbidity assay, radioimmunoassay), immunoprotein types (complement system proteins diagnostic tests, c-reactive protein diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests), and applications (allergy testing, autoimmune disease testing, endocrine testing, infectious disease testing, oncology testing, toxicology testing).
The global immunoprotein diagnostic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global immunoprotein diagnostic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Assay Technology
1.1. Chemiluminescence Assay
1.2. Enzyme Based Immunoassay
1.3. Immunofluorescence Assay
1.4. Immunoprotein Electrophoresis
1.5. Immunoturbidity Assay
1.6. Radioimmunoassay
2. Immunoprotein Type
2.1. Complement System Proteins Diagnostic Tests
2.2. C-Reactive Protein (CRP) Diagnostic Tests
2.3. Free Light Chain Diagnostic Tests
2.4. Haptoglobin Diagnostic Tests
2.5. Immunoglobulin Diagnostic Tests
2.6. Prealbumin Diagnostic Tests
3. Application
3.1. Allergy Testing
3.2. Autoimmune Disease Testing
3.3. Endocrine Testing
3.4. Infectious Disease Testing
3.5. Oncology Testing
3.6. Toxicology Testing
4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World
5. Company Profiles
5.1. Abbott Laboratories, Inc.
5.2. Abcam PLC
5.3. DiaSorin SPA
5.4. Enzo Life Sciences, Inc.
5.5. Fujirebio Diagnostics, Inc.
5.6. Omega Diagnostics Group Plc
5.7. Randox Laboratories Ltd.
5.8. Roche Holding AG
5.9. Siemens AG
5.10. The Binding Site Group Ltd.
5.11. Thermo Fisher Scientific, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Immunoprotein Diagnostic Testing Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/immunoprotein-diagnostic-testing-market/
The global immunoprotein diagnostic testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The global immunoprotein diagnostic testing market segmentation is based on assay technologies (chemiluminescence assay, enzyme based immunoassay, immunofluorescence assay, immunoprotein electrophoresis, immunoturbidity assay, radioimmunoassay), immunoprotein types (complement system proteins diagnostic tests, c-reactive protein diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests), and applications (allergy testing, autoimmune disease testing, endocrine testing, infectious disease testing, oncology testing, toxicology testing).
The global immunoprotein diagnostic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global immunoprotein diagnostic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Assay Technology
1.1. Chemiluminescence Assay
1.2. Enzyme Based Immunoassay
1.3. Immunofluorescence Assay
1.4. Immunoprotein Electrophoresis
1.5. Immunoturbidity Assay
1.6. Radioimmunoassay
2. Immunoprotein Type
2.1. Complement System Proteins Diagnostic Tests
2.2. C-Reactive Protein (CRP) Diagnostic Tests
2.3. Free Light Chain Diagnostic Tests
2.4. Haptoglobin Diagnostic Tests
2.5. Immunoglobulin Diagnostic Tests
2.6. Prealbumin Diagnostic Tests
3. Application
3.1. Allergy Testing
3.2. Autoimmune Disease Testing
3.3. Endocrine Testing
3.4. Infectious Disease Testing
3.5. Oncology Testing
3.6. Toxicology Testing
4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World
5. Company Profiles
5.1. Abbott Laboratories, Inc.
5.2. Abcam PLC
5.3. DiaSorin SPA
5.4. Enzo Life Sciences, Inc.
5.5. Fujirebio Diagnostics, Inc.
5.6. Omega Diagnostics Group Plc
5.7. Randox Laboratories Ltd.
5.8. Roche Holding AG
5.9. Siemens AG
5.10. The Binding Site Group Ltd.
5.11. Thermo Fisher Scientific, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories